This looks to be a hot day in the nation's medicine chest, so we are plotting ways to stay cool while saving energy. Wish us luck. Meanwhile, the usual mid-week meetings and deadlines loom, so here are some items to help you get through it all....
Glaxo's Fails To Win UK Backing Over Cost (Bloomberg News)
Pfizer Plant Sale In Ireland Falls Through (The Irish Examiner)
Angiotech Reorganizes To Shift Focus (Yahoo/Reuters)
Pfizer Explosion Suit To Reach Jury By Fall (The Day)
Pharma Wants India To Review Price Controls (The Economic Times)
1 Comment
From the Pfizer explosion article: "...the product warnings were appropriate under OSHA and industry standards and that Callery had recommended refrigeration of the compound"
As the plaintiff in this case, Pfizer is lucky there is no pre-emption law involved.